122 related articles for article (PubMed ID: 21542758)
1. Dialysis catheters and recombinant tissue plasminogen activator.
Allon M
N Engl J Med; 2011 May; 364(18):1779; author reply 1779-80. PubMed ID: 21542758
[No Abstract] [Full Text] [Related]
2. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.
Hemmelgarn BR; Moist LM; Lok CE; Tonelli M; Manns BJ; Holden RM; LeBlanc M; Faris P; Barre P; Zhang J; Scott-Douglas N;
N Engl J Med; 2011 Jan; 364(4):303-12. PubMed ID: 21268722
[TBL] [Abstract][Full Text] [Related]
3. Management of a Patient with Catheter-Related Bloodstream Infection.
Lok CE
Clin J Am Soc Nephrol; 2017 Nov; 12(11):1873-1877. PubMed ID: 28679561
[No Abstract] [Full Text] [Related]
4. Tackling the Achilles' heel of hemodialysis.
Winkelmayer WC
N Engl J Med; 2011 Jan; 364(4):372-4. PubMed ID: 21268730
[No Abstract] [Full Text] [Related]
5. Thrombolytics for occluded catheters.
Horne MK
Crit Care Med; 2004 Oct; 32(10):2146-7. PubMed ID: 15483427
[No Abstract] [Full Text] [Related]
6. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
[TBL] [Abstract][Full Text] [Related]
7. Establishing an alteplase dosing protocol for hemodialysis-catheter thrombosis.
Nguyen TV; Dikun M
Am J Health Syst Pharm; 2004 Sep; 61(18):1922-4. PubMed ID: 15487882
[No Abstract] [Full Text] [Related]
8. Clinical outcomes of management of CVAD occlusions.
Peng C; Monagle P; Newall F
Arch Dis Child; 2011 Sep; 96(9):885-7. PubMed ID: 21398316
[TBL] [Abstract][Full Text] [Related]
9. Using alteplase to clear occlusions.
Moureau N
Nursing; 2002 Jan; 32(1):73. PubMed ID: 12926500
[No Abstract] [Full Text] [Related]
10. Interventions for restoring patency of occluded central venous catheter lumens (Review).
van Miert C; Hill R; Jones L
Evid Based Child Health; 2013 Mar; 8(2):695–749. PubMed ID: 24482900
[No Abstract] [Full Text] [Related]
11. Tissue plasminogen activator for blocked peritoneal dialysis catheters.
Krishnan RG; Moghal NE
Pediatr Nephrol; 2006 Feb; 21(2):300. PubMed ID: 16252099
[TBL] [Abstract][Full Text] [Related]
12. Alteplase use for clotted catheters.
Macon EJ
Semin Dial; 2002; 15(1):72. PubMed ID: 11874599
[No Abstract] [Full Text] [Related]
13. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
14. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
Thomas CM; Zhang J; Lim TH; Scott-Douglas N; Hons RB; Hemmelgarn BR;
ASAIO J; 2007; 53(4):485-8. PubMed ID: 17667236
[TBL] [Abstract][Full Text] [Related]
15. Alteplase (TPA) for clotted dialysis catheters.
Hathiwala SC; Hristea I; Khalili V
Int J Artif Organs; 2000 Oct; 23(10):668-9. PubMed ID: 11075895
[No Abstract] [Full Text] [Related]
16. Efficacy of local instillation of recombinant tissue plasminogen activator for restoring occluded central venous catheters in neonates.
Soylu H; Brandão LR; Lee KS
J Pediatr; 2010 Feb; 156(2):197-201.e1. PubMed ID: 19969306
[TBL] [Abstract][Full Text] [Related]
17. Managing catheter dysfunction for better patient outcomes: a team approach.
Dinwiddie LC
Nephrol Nurs J; 2004; 31(6):653-60, 671; quiz 661-2. PubMed ID: 15686329
[TBL] [Abstract][Full Text] [Related]
18. Stability and sterility of recombinant tissue plasminogen activator at -30 degrees C.
Wiernikowski JT; Crowther M; Clase CM; Ingram A; Andrew M; Chan AK
Lancet; 2000 Jun; 355(9222):2221-2. PubMed ID: 10881901
[TBL] [Abstract][Full Text] [Related]
19. Reteplase for clearance of occluded venous catheters.
Owens L
Am J Health Syst Pharm; 2002 Sep; 59(17):1638-40. PubMed ID: 12224345
[No Abstract] [Full Text] [Related]
20. Management of a large organized intraatrial catheter-tip thrombus in a child with acquired immunodeficiency syndrome using escalating tissue plasminogen activator infusions.
Mathur M; Desai N; Sharma J; Rao SP; Goldman GM
Pediatr Crit Care Med; 2005 Jan; 6(1):79-82. PubMed ID: 15636665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
